AAAAAA

   
Results: 1-14 |
Results: 14
STATISTICAL ISSUES FOR HIV SURROGATE END-POINTS - POINT COUNTERPOINT/
Authors: ALBERT JM IOANNIDIS JPA REICHELDERFER P CONWAY B COOMBS RW CRANE L DEMASI R DIXON DO FLANDRE P HUGHES MD KALISH LA LARNTZ K LIN DY MARSCHNER IC MUNOZ A MURRAY J NEATON J PETTINELLI C RIDA W TAYLOR JMG WELLES SL
Citation: Jm. Albert et al., STATISTICAL ISSUES FOR HIV SURROGATE END-POINTS - POINT COUNTERPOINT/, Statistics in medicine, 17(21), 1998, pp. 2435-2462
ANALYZING SURVIVAL IN THE PRESENCE OF AN AUXILIARY VARIABLE
Authors: FLANDRE P
Citation: P. Flandre, ANALYZING SURVIVAL IN THE PRESENCE OF AN AUXILIARY VARIABLE, Statistics in medicine, 17(2), 1998, pp. 239-241
A RANDOMIZED TRIAL OF 3 MAINTENANCE REGIMENS GIVEN AFTER 3 MONTHS OF INDUCTION THERAPY WITH ZIDOVUDINE, LAMIVUDINE, AND INDINAVIR IN PREVIOUSLY UNTREATED HIV-1-INFECTED PATIENTS
Authors: PIALOUX G RAFFI F BRUNVEZINET F MEIFFREDY V FLANDRE P GASTAUT JA DELLAMONICA P YENI P DELFRAISSY JF ABOULKER JP
Citation: G. Pialoux et al., A RANDOMIZED TRIAL OF 3 MAINTENANCE REGIMENS GIVEN AFTER 3 MONTHS OF INDUCTION THERAPY WITH ZIDOVUDINE, LAMIVUDINE, AND INDINAVIR IN PREVIOUSLY UNTREATED HIV-1-INFECTED PATIENTS, The New England journal of medicine, 339(18), 1998, pp. 1269-1276
CYTOMEGALOVIRUS (CMV) VIREMIA AND THE CD4(-IMMUNODEFICIENCY-VIRUS() LYMPHOCYTE COUNT AS PREDICTORS OF CMV DISEASE IN PATIENTS INFECTED WITHHUMAN)
Authors: GERARD L LEPORT C FLANDRE P HOUHOU B SALMONCERON D PEPIN JM MANDET C BRUNVEZINET F VILDE JL
Citation: L. Gerard et al., CYTOMEGALOVIRUS (CMV) VIREMIA AND THE CD4(-IMMUNODEFICIENCY-VIRUS() LYMPHOCYTE COUNT AS PREDICTORS OF CMV DISEASE IN PATIENTS INFECTED WITHHUMAN), Clinical infectious diseases, 24(5), 1997, pp. 836-840
RISK-FACTORS FOR ONSET OF CUTANEOUS AND MUCOCUTANEOUS LEISHMANIASIS IN BOLIVIA
Authors: ALCAIS A ABEL L DAVID C TORREZ ME FLANDRE P DEDET JP
Citation: A. Alcais et al., RISK-FACTORS FOR ONSET OF CUTANEOUS AND MUCOCUTANEOUS LEISHMANIASIS IN BOLIVIA, The American journal of tropical medicine and hygiene, 57(1), 1997, pp. 79-84
EVIDENCE FOR A MAJOR GENE CONTROLLING SUSCEPTIBILITY TO TEGUMENTARY LEISHMANIASIS IN A RECENTLY EXPOSED BOLIVIAN POPULATION
Authors: ALCAIS A ABEL L DAVID C TORREZ ME FLANDRE P DEDET JP
Citation: A. Alcais et al., EVIDENCE FOR A MAJOR GENE CONTROLLING SUSCEPTIBILITY TO TEGUMENTARY LEISHMANIASIS IN A RECENTLY EXPOSED BOLIVIAN POPULATION, American journal of human genetics, 61(4), 1997, pp. 968-979
THE USE OF AUXILIARY EVENTS TO IMPROVE THE ANALYSIS OF SURVIVAL FOR HIV-INFECTED PATIENTS - APPLICATION TO THE FRENCH PROSPECTIVE MULTICENTER COHORT (SEROCO)
Authors: FLANDRE P BOUFASSA F GERARD L CARRE N PERSOZ A MEYER L ROUZIOUX C BARY M BURGARD M DELLAMONICA P DURANT J GALLAIS H MARS ME GALLAIS J DORMONT J DELFRAISSY JF LEVY A BOUE F LEFRERE JJ LERABLE J JOUBERT L CASSUTO JP REBOULOT B QUARANTA M DUPONT B BEUZELIN C FOURNIER S VITTECOQ D BOLLIOT C PECHALAT MT HERSON S COUTELLIER A GASTAUT JA DHIVER C DROGOUL MP SERENI D GOMEZ V BACHMEYER C VILDE JL LEPORT C COLASSANTE U KATLAMA C BRUCKER G SOBEL A DUVAL J MAJERHOLD C DEFORGES L KAZATCHKINE M VELLAY A BUISSON M LEBRAS P GOUJARD C QUERTAINMONT Y ANDRIEU JM EVEN P GUILLEVIN L JAROUSSE B TROGOFF B
Citation: P. Flandre et al., THE USE OF AUXILIARY EVENTS TO IMPROVE THE ANALYSIS OF SURVIVAL FOR HIV-INFECTED PATIENTS - APPLICATION TO THE FRENCH PROSPECTIVE MULTICENTER COHORT (SEROCO), Journal of acquired immune deficiency syndromes and human retrovirology, 12(2), 1996, pp. 174-181
ON THE USE OF AUXILIARY DATA TO ESTIMATE THE SURVIVAL FUNCTION AND ITS VARIANCE - AN APPLICATION TO ACQUIRED-IMMUNODEFICIENCY-SYNDROME
Authors: FLANDRE P
Citation: P. Flandre, ON THE USE OF AUXILIARY DATA TO ESTIMATE THE SURVIVAL FUNCTION AND ITS VARIANCE - AN APPLICATION TO ACQUIRED-IMMUNODEFICIENCY-SYNDROME, Journal of clinical epidemiology, 49(8), 1996, pp. 899-905
LIFE EXPECTANCY IN HOSPITALIZED-PATIENTS WITH AIDS - PROGNOSTIC FACTORS ON ADMISSION
Authors: GERARD L FLANDRE P RAGUIN G LEGALL JR VILDE JL LEPORT C
Citation: L. Gerard et al., LIFE EXPECTANCY IN HOSPITALIZED-PATIENTS WITH AIDS - PROGNOSTIC FACTORS ON ADMISSION, Journal of palliative care, 12(1), 1996, pp. 26-30
A 2-STAGE PROCEDURE FOR SURVIVAL STUDIES WITH SURROGATE END-POINTS
Authors: FLANDRE P OQUIGLEY J
Citation: P. Flandre et J. Oquigley, A 2-STAGE PROCEDURE FOR SURVIVAL STUDIES WITH SURROGATE END-POINTS, Biometrics, 51(3), 1995, pp. 969-976
THE NUTRITIONAL BALANCE OF THE DIET OF TH E ADULT-POPULATION OF GENEVA
Authors: BERNSTEIN M MORABIA A COSTANZA MC LANDIS JR ROSS A FLANDRE P LUONG BL KUMANYIKA S SORENSON A LOCALIO R
Citation: M. Bernstein et al., THE NUTRITIONAL BALANCE OF THE DIET OF TH E ADULT-POPULATION OF GENEVA, Sozial- und Praventivmedizin, 39(6), 1994, pp. 333-344
PREDICTIVE CAPABILITY OF PROPORTIONAL HAZARDS REGRESSION
Authors: OQUIGLEY J FLANDRE P
Citation: J. Oquigley et P. Flandre, PREDICTIVE CAPABILITY OF PROPORTIONAL HAZARDS REGRESSION, Proceedings of the National Academy of Sciences of the United Statesof America, 91(6), 1994, pp. 2310-2314
ASSOCIATION OF ELEVATED LIPOPROTEIN(A) LEVELS AND CORONARY HEART-DISEASE IN NIDDM PATIENTS - RELATIONSHIP WITH APOLIPOPROTEIN(A) PHENOTYPES
Authors: RUIZ J THILLET J HUBY T JAMES RW ERLICH D FLANDRE P FROGUEL P CHAPMAN J PASSA P
Citation: J. Ruiz et al., ASSOCIATION OF ELEVATED LIPOPROTEIN(A) LEVELS AND CORONARY HEART-DISEASE IN NIDDM PATIENTS - RELATIONSHIP WITH APOLIPOPROTEIN(A) PHENOTYPES, Diabetologia, 37(6), 1994, pp. 585-591
REDUCTION IN TRIAL DURATION USING AN AUXI LIARY EVENT
Authors: FLANDRE P
Citation: P. Flandre, REDUCTION IN TRIAL DURATION USING AN AUXI LIARY EVENT, Revue d'epidemiologie et de sante publique, 41(6), 1993, pp. 494-500
Risultati: 1-14 |